Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

 SummaryNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Company
Actavis nyse|ACT became the new name for global pharmaceutical Company Watson Pharmaceuticals Inc. on January 24, 2013. At the same time the Company began trading under a new symbol (NYSE:ACT on the New York Stock Exchange. The name change followed the Companys acquisition of the global... 
Surperformance© rating of Actavis Inc
Trading Rating : Investor Rating :
More about the company
Financials ($)
Sales 2013 8 048 M
EBIT 2013 1 691 M
Net income 2013 478 M
Debt 2013 5 521 M
Yield 2013 -
Sales 2014 8 473 M
EBIT 2014 1 874 M
Net income 2014 918 M
Debt 2014 3 924 M
Yield 2014 -
PER 2013 26,33
PER 2014 17,45
EV / Sales 2013 2,77x
EV / Sales 2014 2,44x
Capitalization 16 752 M
More Financials
Latest news on ACTAVIS INC
3h ago ACTAVIS INC: Before the Bell Scans: Dynavax Technologies, Warner Chilcott, Avan..
4h ago ACTAVIS INC: Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Inf..
1d ago ACTAVIS INC: Actavis Files Registration Statement on Form S-4 in Connection wit..
2d ago ACTAVIS INC: U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC ..
2d agoDJSupreme Court Rules Drug-Company Settlements Can Face Antitrust Scrutiny
2d agoDJSupreme Court Rules Drug-Company Settlements Can Face Antitrust Scrutiny
06/11 ACTAVIS INC: Actavis and Medicines360 Announce Partnership to Advance Women's A..
06/10 Tax leverage helps make Irish pharma a popular target
06/07 ACTAVIS INC: Actavis Confirms Generic Diprivan® Patent Challenge
06/05 ACTAVIS INC: Actavis Confirms Generic Safyral® Patent Challenge
06/05 Sweden's Meda sale talks founder on valuation - source
06/04 ACTAVIS INC: Actavis, Inc. to Present at the Goldman Sachs 34th Annual Global H..
More news
Forum ACTAVIS INC
Advertisement
Income Statement Evolution
Actavis Inc : Income Statement Evolution
More Financials
EPS Revisions
Actavis Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.